n
 
About Us       Blog       Clients       Disclaimer       Market Basics       Partners       Quotes & News       Video       Contact Us
The QualityStocks Daily Newsletter for Thursday, November 3rd, 2016

The QualityStocks
Daily Stock List

graphic
graphic

Leo Motors, Inc. (LEOM)

Wallstreetlivechat, Bull Trends, RedChip, Alternative Energy, OTCPicks, Penny Stock Rumble, Stock Guru, FeedBlitz, DrStockPick, Bestotc, StockHotTips, PennyOmega, CRWEWallStreet, CRWEFinance, and Princeton Research reported earlier on Leo Motors, Inc. (LEOM), and we report on the Company today, here at the QualityStocks Daily Newsletter.

Leo Motors, Inc. engages in the research and development (R&D) of multiple products, prototypes, and conceptualizations founded on proprietary, patented, and patent-pending electric power generation, drive train, and storage technologies. Its products include the E-Box electric energy storage system for solar and wind power generation devices; and EV components, which assimilate electric batteries with electric motors, including EV Controllers that use a mini-computer to control torque drive. Leo Motors has its headquarters in South Korea.

Regarding Leo Motors’ family of businesses, LGM, Co. Ltd. is a subsidiary of Leo Motors. It developed an electric power system for small and medium-sized fishing and power boats as the primary propulsion system. Moreover, Leo Korea launched South Korea’s first high-speed electric vehicle.

Leo Motors Factory I and Leo Motors Factory II are "high end" maintenance facilities. These are equipped and staffed to specialize in repairing hand-made luxury cars. Leo Trading is an exclusive dealership and it is known for and specializes in trading luxury cars.

In addition, Leo Tera Factory, Inc. is developing a “Hybrid Ultracapacitor,” a synthetic battery. It has energy-storage capacity comparable to that of a lithium battery of equivalent dimensions. It can deliver energy fast and it can be charged up in minutes or even seconds. Furthermore, Leo Senyuan Leo is a joint venture (JV) agreement with Fushun Jinyuan Technology Machinery Manufacturing Co., Ltd. in Fushun City in Liaoning Province of China. Senyuan Leo will develop, manufacture, as well as sell electric cars in China and worldwide.

Leo Motors has commenced marketing its 60kW power train kits for compact passenger cars and small trucks, and its 120kW kits for ICE passenger cars, buses, and trucks under 5,000cc. It has also developed a 240kW kit for up to 10,000cc buses and trucks.

Leo Motors’ goals for the next months include focusing on the capitalization of the Company; concentrating on the sale of the E-Boats and E-Box; business development in China via establishing a JV company in China, and in Japan; and continuing with R&D of its EV's, electric boats, and related products (as capital permits).

With the support of government officials of Henan, China, Leo Motors and Zhong Ji Well Parking System Co., Ltd. (ZJWP) signed a Memorandum of Understanding (MoU) to set up a JV company centered on battery production, the electric boat business, and the Connected Vehicle business founded on Internet of Things (IoT) platforms. The MoU was facilitated by the city government of Xuchang who invited Leo Motors.

Recently, Leo Motors’ subsidiary, LGM, Co. Ltd., unveiled two electric power trains for sailing yachts at the "Grand Pavois 2016" international boat show in La Rochelle, France. The power trains include inboard and outboard 90 horse power (67 kW) electric propulsion systems. LGM's participation of this show was completely subsidized by the Korean government because LGM has designation as an advanced ocean technology leader in Korea.

Leo Motors, Inc. (LEOM), closed Thursday's trading session at $0.1097, up 4.86%, on 306,030 volume with 21 trades. The average volume for the last 60 days is 95,351 and the stock's 52-week low/high is $0.0882/$0.43.

FluoroPharma Medical, Inc. (FPMI)

INO.com Market Report, TaglichBrothers, Streetwise Reports, Tiny Gems, and MissionIR reported previously on FluoroPharma Medical, Inc. (FPMI), and we highlight the Company today, here at the QualityStocks Daily Newsletter.

FluoroPharma Medical, Inc. specializes in the development of novel diagnostic imaging products that use Positron Emission Tomography (PET) technology for the detection and assessment of disease before clinical manifestation. The Company is a biopharmaceutical enterprise engaged in the discovery and development of proprietary PET imaging products to evaluate cardiac disease at the cellular and molecular levels. FluoroPharma Medical has licensed technology from the Massachusetts General Hospital in Boston, Massachusetts. The Company is headquartered in Montclair, New Jersey.

Patents related to FluoroPharma Medical’s portfolio of imaging compounds have been issued in the U.S, Europe, China, Japan, Canada, Australia, Finland, Portugal, Ireland and Mexico. FluoroPharma’s initial focus is the development of innovative PET imaging agents. It is advancing two products in clinical trials for assessment of acute and chronic forms of coronary artery disease.

The design of these first in class agents is to target, quickly, myocardial cells. Other products in development include agents for the detection of inflamed atherosclerotic plaque in peripheral arteries, agents with the potential to image Alzheimer's disease, and agents that could potentially be used for imaging specific cancers.

FluoroPharma has its BFPET PET Scan Imaging Agent. BFPET is a Flourine-18 labeled tracer. The design of it is to enter the myocardial cells in direct proportion to blood flow and cell membrane potential. These are two of the most important physiological indicators upon which suitable blood supply to the heart depends. The design of BFPET has been to differentiate among those cells of the myocardium, which may be ischemic, infarcted and those that are healthy.
 
CardioPET™ is one of FluoroPharma's first in class PET imaging products. CardioPET™ is a perfusion and fatty acid uptake indicator. The design of it is for use as a cardiac imaging agent. It may be a more specific alternative to currently available diagnostic tests. FluoroPharma Management believes its pharmacokinetic characteristics could be especially valuable in patients who are unable to exercise.
 
In June 2016, FluoroPharma Medical announced that it entered into a nonbinding Letter of Intent (LOI) with Ground Fluor Pharmaceuticals, Inc. (GFP) to acquire GFP. The transaction is conditional on the close of adequate financing to fund the operations of the combined company, as well as due diligence review. FluoroPharma Medical’s intention is to execute the transaction with a subsidiary of FluoroPharma acquiring all shares of closely held GFP by payment with restricted stock, not to exceed most of FluoroPharma Medical's outstanding shares.

In October, FluoroPharma Medical announced that it has been collaborating with Philips for data management in combination with its Phase II clinical trials for its lead agent CardioPET (18-F FCPHA). Safety and image data from the CardioPET study was presented at the European Association of Nuclear Medicine Annual Congress in Barcelona, Spain, on October 16, 2016.

FluoroPharma Medical, Inc. (FPMI), closed Thursday's trading session at $0.14, even for the day, on 59,000 volume with 7 trades. The average volume for the last 60 days is 24,224 and the stock's 52-week low/high is $0.1305/$0.37.

Catasys, Inc. (CATS)

ProfitableTrading, Marketbeat.com, Wall Street Mover, The Street, Stock Gumshoe, PennyPickAlerts, Investopedia, and Fortune Stock Alerts reported earlier on Catasys, Inc. (CATS), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Catasys, Inc. is a provider of proprietary health management services to health insurers and employers. The Company is a provider of proprietary data, predictive analytics, and modeling based behavioral health management services for health plans. Catasys provides specialized health management services via a network of licensed and company managed health care providers. The Company formed to serve health care payors, and it provides unique and integrated substance dependence treatment solutions for its members. Catasys has its corporate headquarters in Los Angeles, California.  

The Catasys substance dependence program improves member health, thus decreasing overall costs. The proprietary program addresses substance dependence as a chronic disease. The program focuses on the whole health of the member. The program delivers integrated medical and psychosocial interventions in combination with long-term care coaching. Catasys provides its proprietary OnTrak integrated substance dependence solutions for third-party payors in numerous states.
 
The design of Catasys’ OnTrak program is to improve member health and at the same time reduce costs to the insurer through employing patient centric treatment that integrates evidence based medical and psychosocial interventions along with care coaching in a 52-week outpatient program. OnTrak-H is a 52-week, multi-phase program in which enrolled members receive medical and psychosocial interventions, and also intensive care coaching.

Catasys presently operates OnTrak programs in Florida, Georgia, Illinois, Kansas, Kentucky, Louisiana, Massachusetts, Missouri, North Carolina, New Jersey, Oklahoma, Pennsylvania, South Carolina, Tennessee, Texas, Virginia, West Virginia and Wisconsin. OnTrak is improving member health and, simultaneously, is demonstrating reduced inpatient and emergency department utilization driving a greater than 50 percent reduction in total health care costs for enrolled members.

This past July, Catasys announced that it extended its OnTrak™-H solution in Florida to Medicare Advantage members with one of the nation's foremost health plans.  The addition of Medicare members to this plan's existing program means their eligible commercial and Medicare Advantage members will be covered under OnTrak-H.

Catasys, Inc. (CATS), closed Thursday's trading session at $0.9159, up 11.70%, on 50,126 volume with 33 trades. The average volume for the last 60 days is 32,025 and the stock's 52-week low/high is $0.245/$1.55.

Resort Savers, Inc. (RSSV)

Promotion Stock Secrets, AllPennyStocks, OTC Markets Group, Tip.us, Stock Commander, and Pennybuster reported on Resort Savers, Inc. (RSSV), and we are highlighting the Company as well, here at the QualityStocks Daily Newsletter.

Resort Savers, Inc. is a strategic investment and development enterprise. It is focusing on identifying and acquiring high demand, revenue-generating assets. At present, the Company is developing and investing in the oil and gas industry and real estate development. Resort Savers has its headquarters in Shenzhen, China.

Resort Savers builds its asset portfolio via strategic acquisitions. Moreover, the Company is set to enter the cardboard packaging industry through acquiring Kashi Jinju Color Printing Packaging Co. Ltd. (Kashi). Resort Savers’ assets include Kashi and WorxAmerica. Resort Savers signed a Definitive Letter of Intent (LOI) to acquire Kashi.  Kashi is based in Northwest China. It is a large, industrial scale cardboard processing and packaging enterprise.

Regarding WorxAmerica, this business designs automated solutions for industrial, environmental and energy industries to improve efficiency and systems output. In January 2015, Resort Savers bought a 20 percent equity stake in WorxAmerica for a $2 Million USD investment.

Resort Savers’ wholly-owned subsidiary, Xing Rui International Investment Holding Group, Ltd., by way of its China corporation subsidiary, Hua Xin Chang Rong (Shenzhen) Technology Service Company Limited (Hua Xin Chang), bought a 60 percent majority interest in Shenzhen Amuli Industrial Development Co. Ltd. (Amuli). This transaction closed upon the issuance of the shares of Resort Savers’ common stock and the transfer of the shares of Amuli to Hua Xin Chang in October 2015.

Resort Savers announced (in October 2015) that it signed a Letter of Intent (LOI) to acquire Beijing Yan Dong Hao Teng Hua Gong (Beijing Yan Dong). This is a large oil-company headquartered in China. Beijing Yan Dong owns dozens of oil tanks and stations throughout China.

Recently, Resort Savers provided an update on its majority-owned Kvass health beverage producer, Shenzhen Amuli Industrial Development Company Limited (Amuli). Amuli was in the process of expanding production facilities. It had been ordered to move its factory to a new location, an expense paid for by the Chinese government. Now, the factory has been officially moved to its new address -  Shen Zhen Shi Long Hua Xin Qu Guan Lan Da Dao 152 Hao Tang Zheng Ke Ji Yuan 1 Dong 1 Lau.

Amuli is the brand name of the Russian drink Kvass. This is a traditional Slavic and Baltic fermented beverage usually made from black or regular rye bread. It is especially popular in Russia, Latvia, Lithuania, Belarus and Ukraine, and in Harbin and Xinjiang, China. Kvass has classification as a non-alcoholic drink by Russian standards. Kvass can be flavored with fruits or with herbs.

Resort Savers, Inc. (RSSV), closed Thursday's trading session at $0.234, up 2.81%, on 232,790 volume with 41 trades. The average volume for the last 60 days is 28,865 and the stock's 52-week low/high is $0.20/$0.6992.

HedgePath Pharmaceuticals, Inc. (HPPI)

BUYINS.NET reported earlier on HedgePath Pharmaceuticals, Inc. (HPPI), and we report on the Company today, here at the QualityStocks Daily Newsletter.

HedgePath Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It discovers, develops, and plans to commercialize pioneering therapeutics for patients with cancer. It is looking to repurpose the Food and Drug Administration (FDA) approved antifungal pharmaceutical itraconazole as a potential treatment for cancer. OTCQB-listed, HedgePath Pharmaceuticals is headquartered in Tampa, Florida.

HedgePath is the exclusive U.S. licensee of a patented formulation of itraconazole, named SUBA-Itraconazole. Clinical studies have shown it to have greater bioavailability than generic itraconazole. The Hedgehog signaling pathway is a major regulator of cellular processes in vertebrates. This includes cell differentiation, tissue polarity, and cell proliferation.  

HedgePath believes (based on published research) that inhibiting the Hedgehog pathway could delay or possibly prevent the development of certain cancers in humans. Taking advantage of research undertaken by key investigators in the field, HedgePath Pharmaceuticals’ plan is to explore the effectiveness of SUBA-Itraconazole as an anti-cancer agent and to pursue its potential commercialization.

HedgePath announced in September of 2015 that initial patients received base-line screening and the first of those patients started dosing in the Company’s Phase II(b) clinical trial examining SUBA™ Itraconazole Capsules as a potential therapy for basal cell carcinoma (BCC) in patients with basal cell carcinoma nevus syndrome (BCCNS) - also called Gorlin's Syndrome.

The design of “SUBA technology” (which stands for “super bioavailability”) is to improve the bioavailability of orally administered drugs that are poorly soluble. SUBA-Itraconazole is a patented formulation developed by Mayne Pharma. It has improved absorption and considerably lessened variability versus generic itraconazole.

HedgePath Pharmaceuticals announced this past June that it received notice of Orphan Drug Designation for treatment of patients with Basal Cell Carcinoma Nevus Syndrome (BCCNS) with its oral formulation of SUBA-Itraconazole Capsules.

HedgePath announced in August positive interim data from its continuing, open-label Phase II(b) clinical trial studying the effect of SUBA™-Itraconazole oral capsules in patients with Basal Cell Carcinoma Nevus Syndrome (BCCNS, also called Gorlin Syndrome). Concerning target tumor burden, among those subjects who were dosed for a minimum of 16 weeks, the target tumor burden did not increase in any subject; it was reduced by over 30 percent in 8 of the 13 subjects (62 percent) with an average reduction of 60 percent.

Last month, HedgePath Pharmaceuticals announced further positive interim data from its continuing, open-label Phase II(b) clinical trial studying the effect of SUBA-Itraconazole (SUBA-Cap) oral capsules in patients with Basal Cell Carcinoma Nevus Syndrome (BCCNS) - Gorlin Syndrome.

Eighteen subjects with Basal Cell Carcinoma Nevus Syndrome who had 231 surgically eligible tumors completed 16 weeks of dosing with SUBA™-Itraconazole. Second interim analysis shows a statistically significant mean target tumor burden reduction (P<0.0001) and 11 of 18 trial subjects to date attaining a 30 percent or greater reduction in target tumor burden.

HedgePath Pharmaceuticals, Inc. (HPPI), closed Thursday's trading session at $0.37, down 1.61%, on 39,400 volume with 12 trades. The average volume for the last 60 days is 9,380 and the stock's 52-week low/high is $0.08/$0.6548.

graphic

The QualityStocks
Company Corner

graphic
graphic

Singlepoint, Inc. (SING)

The QualityStocks Daily Newsletter would like to spotlight Singlepoint, Inc. (SING). Today, Singlepoint, Inc. closed trading at $0.0135, up 58.82%, on 16,010,479 volume with 372 trades. The stock’s average daily volume over the past 60 days is 498,253, and its 52-week low/high is $0.0046/$0.018.

Singlepoint, Inc. today announces that SingleSeed (www.singleseed.com), a subsidiary focused on providing credit card processing solutions for the cannabis industry, is awakening from a quiet period to take advantage of increased demand and legislative shifts within the cannabis market. "This is an ideal time to actively engage the marketplace. A couple years ago we established a significant presence as one of the first merchant service providers targeting this industry, and we will be leveraging relations with existing clients to accelerate growth," states SinglePoint CEO Greg Lambrecht. "Additionally, there are a number of other smaller companies in this space that, as part of our overall rollup initiative, we would seek to acquire."

Singlepoint, Inc. (SING) provides mobile technology and marketing solutions that enable companies, nonprofits and religious organizations to conduct business transactions, accept donations, and engage in targeted communication via mobile devices. Through diversification of its own model, the company is also leveraging its core technology to expand into the mobile auctions and daily fantasy sports markets.

SING currently has two fundraising solutions. Text2Bid is an interactive way to increase auction revenues. The technology makes it easy for people to bid in auctions from any text or web-enabled phone. Donate by Text allows nonprofits to securely collect one-time or recurring donations via text. This capability creates a personal experience for the donors, and enables ongoing communication between the donor and nonprofit or event sponsor.

SING's payment solutions include point-of-sale (POS) terminals, loyalty programs, payment processing, phone services and financing. Pay by Text™ enables a business to accept payment transactions and, in essence, turns the user's mobile phone into a point-of-sale device. Operating on the same platform as mobile marketing, Pay by Text is designed to increase revenues, raise the average per-transaction amount, and create a fast, easy and hassle-free method of payment.

As part of its diversification and expansion strategy, SING recently acquired an interest in DraftFury (www.draftfury.com), a company that offers skill-based NBA, NFL and MLB daily fantasy sports (DFS) contests. DraftFury is known for its innovative offerings and originality, and is the first cash-flow-positive DFS enterprise. This transaction places SING in a multi-billion dollar industry expected to generate entry fees of $14.4 billion in 2020. Under the guidance of a leadership team well-versed in technology, engineering, marketing and raising capital, SING anticipates a strong foothold in its chosen markets. Disclaimer

Singlepoint, Inc. Company Blog

Singlepoint, Inc. News:

SinglePoint Subsidiary Awakens from Quiet Period to Capitalize on Increased Accessibility to $6+ Billion Cannabis Industry Cash Transactions

SinglePoint, Inc. Expands Collaboration with RedFynn Technologies, Announces Partnership with United Way of Mesa

Singlepoint, Inc. (SING) Featured Again on MoneyTV with Donald Baillargeon, Oct 28

Medical Transcription Billing, Corp. (MTBC)

The QualityStocks Daily Newsletter would like to spotlight Medical Transcription Billing, Corp. (MTBC). Today, Medical Transcription Billing, Corp. closed trading at $0.8526, up 1.50%, on 4,975 volume with 10 trades. The stock’s average daily volume over the past 60 days is 14,288, and its 52-week low/high is $0.678/$1.78.

Medical Transcription Billing, Corp. (MTBC) is a healthcare information technology (IT) company that provides its fully integrated suite of proprietary web-based solutions and related business services to a diverse field of healthcare individuals and entities specializing in more than 63 areas and spanning 40 U.S. states.

The company went public in July 2014, at which time it also acquired three competitors. Since then, MTBC has steadily expanded its portfolio with seven additional acquisitions of competing healthcare IT companies, the most recent of which – and largest to-date - is Texas-based medical billing company, MediGain, LLC.

Today, MTBC is an award-winning company whose Software-as-a-Service (SaaS) platform helps healthcare providers increase revenues, fine tune their clinical and business decision making, reduce administrative burdens, streamline workflows, and reduce operating costs.

Its current products - electronic health records, practice management, patient engagement and the mHealth app – are fully integrated with core services that include medical billing services, value-added services, consultancy services, medical transcription, scribe services, and business intelligence. Notably, the standard fee for its comprehensive platform is calculated as a percentage of a practice's healthcare-related revenues, and is among the lowest in the industry.

MTBC is ranked among the Deloitte Technology Fast 500 (2009, 2010, 2011, 2012), is a Microsoft® Certified Partner, and has been awarded the Surescripts® White Coat of Quality, while its mHealth app – available for smartphone and tablet devices - is ranked No. 1 on Apple Store and Google Play as the most downloaded app for ICD 9 to ICD 10 conversion.

As a reputable IT provider for the healthcare industry, MTBC has built a client base of thousands of doctors. As a way of thanking them for their loyalty, MTBC recently launched its Client Loyalty Program in which it is awarding 100 shares of its publicly traded common stock to its providers and 1,000 shares for referring other physician practices. New MTBC clients are also eligible to participate and receive awards. Disclaimer

Medical Transcription Billing, Corp. Company Blog

Medical Transcription Billing, Corp. News:

MTBC to Announce Third Quarter 2016 Financial Results and Host Conference Call on November 10

MTBC Achieves Corporate Milestone With Its Most Recent Strategic Acquisition

MTBC Announces the Closing of Its Largest Acquisition to Date

Agora Holdings, Inc. (AGHI)

The QualityStocks Daily Newsletter would like to spotlight Agora Holdings, Inc. (AGHI). Today, Agora Holdings, Inc. closed trading at $0.1799, up 0.06%, on 74,010 volume with 57 trades. The stock’s average daily volume over the past 60 days is 536,585, and its 52-week low/high is $0.01/$0.49.

Agora Holdings, Inc. (AGHI), together with its wholly-owned subsidiary, Geegle Media, is leading a diversified family entertainment and media enterprise through business segments which include: TV on Demand, interactive media, business products and consumer platforms. With its multi-dimensional approach, Geegle Media supports Agora Holdings' mission to deliver innovate and high-quality business solution products and to deliver video content from around the world.

Geegle Media web platforms include; GeegleTV, Frame, 1000Salads, RealtyTV and LobbyTV. Geegle TV is a multi-platform video entertainment website that curates high-quality video content from around the world. In 2016, GeegleTV will serve as co-producer by airing original content. By exposing undiscovered content to millions of users and rendering it shareable to social media, Geegle TV will serve as a marketing partner to local and internationally based TV shows not yet on the open market.

For commercial use, Geegle Media provides a variety of solutions that include web development and billing software for VoIP applications. RealtyTV is its state-of-the-art platform for real estate brokerages. LobbyTV is another of its widely used products by business offices. For individuals, Geegle TV combines radio, On Demand movies, news, sports and children's content.

Geegle Media is also developing 1000salads, an online hub that encourages healthy lifestyles. The portal will feature recipes and products, health-oriented articles and a curated selection of local restaurants and grocers that deliver to the health-conscious user. Currently in its alpha stage of development, 1000salads is gearing up its sales and marketing in preparation for its launch in 2016.

Geegle Media differs from other On Demand providers, such as Netflix and HBO, in that its service is free of constraints such as subscription, fees and penalties. As consumers increasingly opt for personalized sources of entertainment, Agora recognizes the vast opportunities and growth potential provided by the rising popularity of TV On Demand. The company also benefits from strong and visionary management with a track record of bringing innovative ideas to fruition. Disclaimer

Agora Holdings, Inc. Company Blog

Agora Holdings, Inc. News:

Agora Holdings, Inc. Updates FRAME Technology to Expand Business-Use Capabilities

Agora Holdings, Inc. Issues Corporate Update on Current, Future Endeavors

Agora Holdings, Inc. Launches FRAME Social Media App

Net Element, Inc. (NETE)

The QualityStocks Daily Newsletter would like to spotlight Net Element, Inc. (NETE). Today, Net Element, Inc. closed trading at $1.11, even for the day, on 102,527 volume with 469 trades. The stock’s average daily volume over the past 60 days is 466,271, and its 52-week low/high is $0.50/$4.60.

Net Element, Inc. (NETE) operates a payments-as-a-service transactional and value-added services platform for small to medium enterprises in the United States and select emerging markets. Leveraging a network of subsidiaries operating in the mobile payments and value-added transactional services space – including Unified Payments, Aptito and PayOnline – Net Element is committed to promoting consistent and strong growth, as illustrated by its position as one of the South Florida Business Journal's 'Top 25 Fastest-Growing Technology Companies'. In the first seven months of 2016 alone, the company realized a 77 percent year-over-year increase in transactional processing volume when discounting the effects of foreign currency exchange.

A major contributor to this sustained growth has been Net Element's PayOnline subsidiary, which offers state-of-the-art payment technologies that are currently employed by more than 3,000 online enterprises across Europe and Asia. To bolster this position, the company has continued to expand its presence in Central Asia, most recently through the opening of a new office in Kazakhstan, the largest country in the region. Since its first anchor project in Kazakhstan in June 2015, PayOnline has entered agreements with more than 180 online merchants in Central Asia, and the region is expected to offer an opportunity for tremendous growth in the coming years as the proliferation of electronic commerce takes hold.

The growth of PayOnline throughout Eurasia has been accompanied by both awards and industry recognition. Independent analytical agency Markswebb Rank & Report ranked PayOnline as a top five payment acceptance company in its 2016 Internet Acquiring Rank report, and a second analytical agency, Tagline.ru, ranked PayOnline as a leading payment gateway in its 2016 Payment Systems Rating. The company's management team attributes this success to PayOnline's "innovative, customer-focused products and services."

Net Element is led by a seasoned management team offering a unique blend of leadership, vision, experience and creative energy. Oleg Firer, the company's chief executive officer, formerly served as the executive chairman of Unified Payments up until its acquisition by Net Element's TOT Group in April 2013. Under his guidance, Unified Payments achieved rapid growth, earning the top spot on Inc. Magazine's list of fastest-growing companies in 2012. As a result, Firer was recognized by Forbes as one of the 'Five Incredible Entrepreneurs' and by Business Leader Magazine as a 'Top Entrepreneur in South Florida'. Disclaimer

Net Element, Inc. Company Blog

Net Element, Inc. News:

Net Element's PayOnline CEO to Lead Panel at the Biggest Russian Internet Conference

ExLine Becomes a Client of Net Element's PayOnline in Kazakhstan

Dunkin' Donuts Becomes a Client of Net Element's PayOnline in Russia

Moxian, Inc. (MOXC)

The QualityStocks Daily Newsletter would like to spotlight Moxian, Inc. (MOXC). Today, Moxian, Inc. closed trading at $5.24, off by 1.13%, on 893 volume with 7 trades. The stock’s average daily volume over the past 60 days is 177, and its 52-week low/high is $4.30/$10.50.

Moxian, Inc. (MOXC) engages in the business of providing social marketing and promotion platforms designed to help merchants accelerate and advertise their business growth through social media. These products and services enable merchants to run targeted advertising campaigns and promotions, and aim to enhance the interaction between users and merchant clients by using consumer behavior data compiled from the Moxian database of user activities. The company has two primary core products: Moxian+ User App and Moxian+ Business App.

Developed in Shenzhen, China, Moxian integrates social media, entertainment and business intelligence. The Multi-Channel Social Commerce Platform, which includes a variety of tools such as Moxian's proprietary Social Customer Relationship Management (SCRM) system, generates knowledgeable data for merchants. This way, consumers and businesses are able to connect and interact with one another to achieve the concept of "online lifestyle, offline fun."

Moxian+ User App serves as an App driven for consumer users to use the platform, consisting of our proprietary virtual currency (MO-Coin and MO-Points), social networking, redemption centre and game centre. Users can earn MO-Coins by playing games, and then use those coins to redeem prizes sponsored by Moxian and client merchants. This model not only drives registered consumers to Moxian and merchant, but also provides merchants the opportunity to advertise, run marketing campaigns, and learn about their customers through the Platform.

Moxian+ Business App is an independent App with built in Social Customer Relationship Management tool built for merchants. Merchants are able to set up a store on the Moxian platform through this business App, push promotions via a variety of methods offered on the platform and look at generated report customized to their own shop.

Moxian's management team has more than 100 years of combined experience in a variety of pertinent endeavors, including management of private and public enterprise, multi-national organizations, quality, engineering and procurement, finance, marketing, communication and more. Together, Moxian's management team is effecting the company's aim to create and lead a personalized social network platform that best fits users and businesses. Disclaimer

Moxian, Inc. Company Blog

Moxian, Inc. News:

Moxian Adopts Oracle Database Solutions to Support the Latest Payment and Transaction Platform, Enabling Intelligent Big Data

Moxian Enters Into Exclusive Agreement and Development Partnership With Xinhua Media Affiliate

Moxian, Inc. Covered by Crystal Equity Research

graphic

Rate Us
Tell us how we're doing!
Click here to begin your review.

Today's Top 3
Investment Newsletters

graphic

1.

QualityStocks
(SING)

2.

Profitable Trader Authority
(MVES)

3.

StockRockandRoll
(MCWEF)

graphic
By The Numbers Charts
QualitystockTwits

The QualityStocks Public Company Sponsor News

Featured Sponsor

Daily Sponsors
















 

The QualityStocks By The Numbers Report

Click the chart below to see the full report

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market
each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge"
based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.

 

About Us     Archives     Blog     Clients     Disclaimer     Market Basics    Partners      Quotes & News     Video     Contact Us

twitter icon facebook icon

QualityStocks Logo

Copyright © 2006 - 2012. QualityStocks 3370 N. Hayden Rd., Suite 123-591, Scottsdale, AZ 85251